top of page

Cellarity's CEO on harnessing technology to better understand disease from a whole cell approach

Fabrice Chouraqui describes Cellarity's platform and how it is being put to use for indications such as sickle cell disease and MASH.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page